Search Results - "Cong, Ze"

Journal Article

Rattle‐Type Fe3O4@CuS Developed to Conduct Magnetically Guided Photoinduced Hyperthermia at First and Second NIR Biological Windows

by Wu, Ze‐Cong Li, Wei‐Peng Luo, Cheng‐Hung Su, Chia‐Hao Yeh, Chen‐Sheng Published in Advanced functional materials (04.11.2015)

“...A therapeutic carrier in the second near‐infrared (NIR) window is created that features magnetic target, magnetic resonance imaging (MRI) diagnosis, and...”

Journal Article

Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors

by Zhao, Hai-yang Wu, Jiang Zhu, Jing-jing Xiao, Ze-cong He, Chao-chao Shi, Hong-xue Li, Xiao-kun Yang, Shu-lin Xiao, Jian
edited by Cucchiarini, Magali
Published in BioMed research international (11.08.2015)

“...Growth factors are a class of cytokines that stimulate cell growth and are widely used in clinical practice, such as wound healing, revascularization, bone...”

Fulltext

Journal Article

Testing for minimal residual disease in adults with acute lymphoblastic leukemia in Europe: a clinician survey

by Pigneux, Arnaud Montesinos, Pau Cong, Ze Zhang, Xinke Pownell, Anja K Wieffer, Heather McKendrick, Jan Brüggemann, Monika Published in BMC cancer (12.11.2018)

“...In acute lymphoblastic leukemia (ALL), the presence of minimal residual disease (MRD) after induction/consolidation chemotherapy is a strong prognostic factor...”

Fulltext

Journal Article

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States

by Delea, Thomas E Zhang, Xinke Amdahl, Jordan Boyko, Diana Dirnberger, Franziska Campioni, Marco Cong, Ze Published in PharmacoEconomics (01.09.2019)

“...The TOWER and INO-VATE-ALL trials demonstrated the efficacy and safety of blinatumomab and inotuzumab ozogamicin (inotuzumab), respectively, versus...”

Fulltext

Journal Article

Brief Report: A Progression of Fraction Schemes Common to Chinese and U.S. Students

by Anderson Norton Jesse L. M. Wilkins Cong ze Xu Published in Journal for research in mathematics education (01.03.2018)

“...Through their work on the Fractions Project, Steffe and Olive (2010) identified a progression of fraction schemes that describes students' development toward...”

Journal Article

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer

by Hagiwara, May Hagiwara, May Delea, Thomas E Delea, Thomas E Cong, Ze Cong, Ze Chung, Karen Chung, Karen Published in Supportive care in cancer (01.01.2014)

“...Cancer patients with bone metastases (BMets) are predisposed to skeletal complications. Bone-targeted therapies such as denosumab or intravenous...”

Fulltext

Journal Article

Photothermal Ablation: Rattle‐Type Fe3O4@CuS Developed to Conduct Magnetically Guided Photoinduced Hyperthermia at First and Second NIR Biological Windows (Adv. Funct. Mater. 41/20...

by Wu, Ze‐Cong Li, Wei‐Peng Luo, Cheng‐Hung Su, Chia‐Hao Yeh, Chen‐Sheng Published in Advanced functional materials (04.11.2015)

“...As shown on page 6527, an effective, near‐infrared (NIR)‐responsive rattle‐type Fe3O4@CuS nanoparticle containing delocalized Fe3O4 nanoparticles inside a...”

Journal Article

A Progression of Fraction Schemes Common to Chinese and U.S. Students

by Anderson Norton Jesse L M Wilkins Congze Xu Published in Journal for research in mathematics education (01.03.2018)

“...Through their work on the Fractions Project, Steffe and Olive (2010) identified a progression of fraction schemes that describes students' development toward...”

Journal Article

Transfusion burden in non-dialysis chronic kidney disease patients with persistent anemia treated in routine clinical practice: a retrospective observational study

by Fox, Kathleen M Yee, Jerry Cong, Ze Brooks, John M Petersen, Jeffrey Lamerato, Lois Gandra, Shravanthi R Published in BMC nephrology (24.01.2012)

“...Transfusion patterns are not well characterized in non-dialysis (ND) chronic kidney disease (CKD) patients. This study describes the proportion of patients...”

Fulltext

Journal Article

U.S. Pharmaceutical Policy In A Global Marketplace

by Lakdawalla, Darius N Goldman, Dana P Michaud, Pierre-Carl Sood, Neeraj Lempert, Robert Cong, Ze de Vries, Han Gutierrez, Italo Published in Health Affairs (01.01.2009)

“...U.S. consumers generate more pharmaceutical revenue per person than Europeans do. This has led some U.S. policymakers to call for limits on U.S. pharmaceutical...”

Journal Article

Staff Time and Motion Assessment for Administration of Erythropoiesis-Stimulating Agents: A Two-Phase Pilot Study in Clinical Oncology Practices

by Reitan, John F van Breda, Arletta Corey-Lisle, Patricia K Shreay, Sanatan Cong, Ze Legg, Jason Published in Clinical drug investigation (01.05.2013)

“...Erythropoiesis-stimulating agents (ESAs) are used for the management of anaemia in patients with non-myeloid malignancies where anaemia is due to the effect of...”

Fulltext

Journal Article

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

by Matza, Louis S Cong, Ze Chung, Karen Stopeck, Alison Tonkin, Katia Brown, Janet Braun, Ada Van Brunt, Kate McDaniel, Kelly Published in Patient preference and adherence (2013-00-00)

“...Although cost-utility models are often used to estimate the value of treatments for metastatic cancer, limited information is available on the utility of...”

Journal Article

Real-world treatment patterns, comorbidities, and disease-related complications in patients with multiple myeloma in the United States

by Song, Xue Cong, Ze Wilson, Kathleen Published in Current medical research and opinion (02.01.2016)

“...Objectives: To describe multiple myeloma (MM) treatment patterns and comorbidities over time in the US. Research design and methods: Study patients were newly...”

Journal Article

Treatment pattern and unmet need in adults with Philadelphia positive (Ph+) relapsed or refractory (R/R) B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) in EU-5 countries

by Zhang, Xinke Zhang, Lirong Gijsen, Merel Cong, Ze Published in Journal of clinical oncology (20.05.2018)

Journal Article

Healthcare Costs Associated with Adult Philadelphia Chromosome-Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) in the US

by Princic, Nicole Song, Xue Lin, Vincent Cong, Ze Published in Blood (02.12.2016)

“...Abstract Background: Ph- ALL in adults is a very rare disease with poor prognosis. Literature on the economic burden of Ph- ALL in adults is sparse. This study...”

Journal Article

Real-world treatment patterns in adult patients (pts) with B-cell precursor acute lymphoblastic leukemia (BCP ALL) in first hematologic complete remission (CR1) with and without mi...

by Shah, Shweta Rose, Darya Cong, Ze Tibrewala, Shruti Chawla, Anita Zaman, Faraz Published in Journal of clinical oncology (20.05.2019)

“...e18517 Background: B-cell precursor acute lymphoblastic leukemia (BCP ALL) is a rare and debilitating hematologic cancer. Among patients (pts) in complete...”

Journal Article

Cost effectiveness (CE) of blinatumomab (BLIN) versus inotuzumab ozogamicin (INO) in adult patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) with no more t...

by Delea, Thomas E Zhang, Xinke Amdahl, Jordan Boyko, Diana Severin, Franziska Campioni, Marco Cong, Ze Published in Journal of clinical oncology (20.05.2019)

“...e18359 Background: To estimate Incremental CE Ratio (ICER) of BLIN vs INO in adults with R/R S0/S1 ALL based on matching-adjusted indirect comparison (MAIC) of...”

Journal Article

Improvement in the Clinical Global Impression of Change with Voxelotor in Patients with Sickle Cell Disease in the Phase 3 HOPE Trial

by Smith, Wally R Hankins, Jane S Abboud, Miguel R Cong, Ze Sorof, Jonathan Gray, Sarah Hoppe, Carolyn Telfer, Paul Published in Blood (05.11.2020)

“...Background: Patients with sickle cell disease (SCD) experience varied salient symptoms that impact their health-related quality of life, which incorporates...”

Journal Article

by Topp, Max S Zimmerman, Zachary Cannell, Paul Dombret, Hervé Maertens, Johan Stein, Anthony Franklin, Janet Tran, Qui Cong, Ze Schuh, Andre C Published in Blood (28.06.2018)

“...In the phase 3 TOWER study, blinatumomab significantly improved overall survival in adults with relapsed or refractory (R/R) Philadelphia chromosome-negative...”

Journal Article

A Systematic Literature Review (SLR) of Clinical Outcomes after Stem Cell Transplantation (SCT) in Adult Acute Lymphoblastic Leukemia (ALL) Patients with or without Minimal Residua...

by Turner, Monica Shah, Shweta Martin, Amber Cong, Ze Stein, Anthony S Published in Blood (29.11.2018)

“...Abstract Background: Most adult patients with ALL will achieve a complete hematologic remission following frontline therapy, but approximately 40% of patients...”

1
2
3
4
5
6
7
8
9
10
11
Next »
[21]

Narrow search